Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per specialist: William Abraham, MD
Woman and Man Max 99 years
William Abraham, MD
Update Il y a 4 ans
Sensible Medical Innovations Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients
Multi center, randomized controlled study, to determine if a significant decrease in the rate of heart failure re-hospitalizations occurs during a follow-up period when - ReDS guided treat...
Country
None
organs
None
Specialty
None
Opened trial
More information
Woman and Man Max 99 years
William Abraham, MD
Update Il y a 4 ans
Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)
The EchoCRT trial evaluates the effects of Cardiac Resynchronization Therapy (CRT) on mortality and morbidity of subjects with heart failure due to left ventricular systolic dysfunction, a...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
William Abraham, MD
Update Il y a 4 ans
FREEDOM - A Frequent Optimization Study Using the QuickOpt Method
The objective of this study is to demonstrate that frequent atrio-ventricular (AV/PV) and inter-ventricular (V-V) delay optimization using QuickOpt in patients with cardiac resynchronizati...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
William Abraham, MD
Update Il y a 4 ans
C-Pulse® System: A Heart Assist Device Clinical Study
Sunshine Heart is sponsoring a prospective, multi-center, randomized trial to assess the safety and efficacy of the C-Pulse® System ("C-Pulse"). The purpose of the study is to determine w...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
William Abraham, MD
Update Il y a 4 ans
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
The purpose of the HOPE4HF trial is to demonstrate the safety and efficacy of the Rheos Baroreflex Activation Therapy System in subjects with heart failure with an EF ≥ 40% in a prospectiv...
Country
None
organs
None
Specialty
None
Closed trial
More information